22-222
Showing 1 - 25 of 3,567
SCN2A-DEE, Epilepsy Trial in Memphis (PRAX-222 - Initial Dose, PRAX-222 - Initial Ascending Doses, PRAX-222 - Optional Ascending
Recruiting
- SCN2A-DEE
- Epilepsy
- PRAX-222 - Initial Dose
- +4 more
-
Memphis, TennesseePraxis Research Site
Feb 10, 2023
Episodic Migraine Trial in Worldwide (AMG334 (70 mg) Pre-Filled Syringe (PFS), Placebo Pre-Filled Syringe (PFS))
Completed
- Episodic Migraine
- AMG334 (70 mg) Pre-Filled Syringe (PFS)
- Placebo Pre-Filled Syringe (PFS)
-
Heidelberg, Australia
- +58 more
Feb 23, 2022
Remote Patient Monitoring in COPD Patients Trial in Spain, Sweden (Remote Patient Monitoring, Usual care)
Completed
- Remote Patient Monitoring in COPD Patients
- Remote Patient Monitoring
- Usual care
-
Barcelona, Catalunya, Spain
- +19 more
Dec 8, 2020
Chronic Kidney Disease, Diabetic Kidney Disease Trial in Worldwide (BAY2327949, Placebo)
Withdrawn
- Chronic Kidney Disease
- Diabetic Kidney Disease
- BAY2327949
- Placebo
-
Linz, Oberösterreich, Austria
- +35 more
May 19, 2021
COPD (COPD) Trial in Worldwide (Tozorakimab, Placebo)
Not yet recruiting
- Chronic Obstructive Pulmonary Disease (COPD)
- Tozorakimab
- Placebo
-
Lincoln, California
- +113 more
Feb 15, 2023
Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Breast Carcinoma Trial in
Not yet recruiting
- Anatomic Stage III Breast Cancer AJCC v8
- +14 more
- Biopsy
- +25 more
-
Portland, OregonOHSU Knight Cancer Institute
Jul 12, 2022
Solid Tumor, Metastatic Cancer Trial in United States (RP-3500, External Beam Radiotherapy (EBRT))
Recruiting
- Solid Tumor
- Metastatic Cancer
- RP-3500
- External Beam Radiotherapy (EBRT)
-
Basking Ridge, New Jersey
- +6 more
Dec 8, 2022
Respiratory Distress Syndrome, Newborn, Premature Birth Trial in Evanston (Poractant Alfa)
Not yet recruiting
- Respiratory Distress Syndrome, Newborn
- Premature Birth
- Poractant Alfa
-
Evanston, IllinoisNorthshore University Healthsystem
Aug 22, 2023
COPD (COPD) Trial in Worldwide (Tozorakimab, Placebo)
Recruiting
- Chronic Obstructive Pulmonary Disease (COPD)
- Tozorakimab
- Placebo
-
Mobile, Alabama
- +199 more
Aug 10, 2022
Acute Myocardial Infarction, Heart Failure Trial in Sweden, United Kingdom (Dapagliflozin, Placebo)
Recruiting
- Acute Myocardial Infarction
- Heart Failure
- Dapagliflozin
- Placebo
-
Alingsås, Sweden
- +112 more
Aug 18, 2022
Umbilical Cord Abnormalities in Prediction of Adverse Pregnancy
Not yet recruiting
- Small for Gestational Age at Delivery
- +3 more
- Umbilical cord measurements & observations
- (no location specified)
Jun 5, 2023
Osteoarthritis of the Knee or Hip Trial in Worldwide (Fasinumab, Placebo)
Completed
- Osteoarthritis of the Knee or Hip
- Fasinumab
- Placebo
-
Birmingham, Alabama
- +149 more
Nov 30, 2021
Acute Myeloid Leukemia Trial in United States (Cyclophosphamide, Fludarabine, KITE-222)
Recruiting
- Acute Myeloid Leukemia
- Cyclophosphamide
- +2 more
-
Stanford, California
- +6 more
Aug 10, 2022
Breast Tumors Trial in Worldwide (PD-0332991, Letrozole, Placebo)
Active, not recruiting
- Breast Neoplasms
- PD-0332991
- +2 more
-
Bellflower, California
- +304 more
Dec 6, 2022
Periodontitis, Diabetes, Type 2 Trial in Istanbul (Non-Surgical Periodontal Treatment)
Completed
- Periodontitis
- Diabetes Mellitus, Type 2
- Non-Surgical Periodontal Treatment
-
Istanbul, TurkeyMarmara University
Nov 11, 2023
Myopic Chorioretinal Atrophy Trial in Nagoya (Pars plana vitrectomy)
Recruiting
- Myopic Chorioretinal Atrophy
- Pars plana vitrectomy
-
Nagoya, Aichi, JapanNagoya city university hospital
Jan 11, 2023
Flap Thickness Versus Pre-determined Surgical Planning Using
Recruiting
- Myopia
- WaveLight® FS200 femtosecond laser
-
Bismarck, North DakotaBismarck Lasik
Aug 12, 2022
Opioid Dependence, Acute Opioid Withdrawal Syndrome Trial in United States (Lofexidine HCl, Placebo, Open Label Lofexidine HCL)
Completed
- Opioid Dependence
- Acute Opioid Withdrawal Syndrome
- Lofexidine HCl
- +2 more
-
Clovis, California
- +17 more
Mar 11, 2022
BRAF V600E-mutant Metastatic Colorectal Cancer Trial in Worldwide (Encorafenib, Binimetinib, Cetuximab)
Active, not recruiting
- BRAF V600E-mutant Metastatic Colorectal Cancer
- Encorafenib
- +5 more
-
Phoenix, Arizona
- +428 more
Mar 7, 2022